BMJ  2008;336 (21 June), doi:10.1136/bmj.a413

Editor's Choice

Key opinion leaders, your time is up

Fiona Godlee, editor, BMJ

fgodlee@bmj.com

The first 150 words of the full text of this article appear below.

We’re lucky in medicine to have an unending supply of mysteries to ponder. Some of these—like why vitamin A supplementation benefits some children while harming others—are amenable to scientific research (doi: 10.1136/bmj.39575.486609.80;doi: 10.1136/bmj.39542.509444.AE). But there are mysteries of a different sort, ones that are in our power as a profession to resolve. Why, for example, is it considered normal for medical leaders to accept personal payment for promoting a company’s drug or device?

This week Ray Moynihan asks whether paid "key opinion leaders" can be independent or are just drug representatives in disguise (doi: 10.1136/bmj.39575.675787.651). His interview with former sales representative Kimberly Elliott suggests the latter. We know from independent studies that paid opinion leaders can increase use of a target drug or device. Even if we didn’t know this, we would have to assume it from industry’s continued funding of "KOLs." Speakers who don’t make enough . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Key opinion leaders: independent experts or drug representatives in disguise?
Ray Moynihan
BMJ 2008 336: 1402-1403. [Extract] [Full Text] [PDF]

Should the drug industry work with key opinion leaders? Yes
Charlie Buckwell
BMJ 2008 336: 1404. [Extract] [Full Text] [PDF]

Should the drug industry work with key opinion leaders? No
Giovanni A Fava
BMJ 2008 336: 1405. [Extract] [Full Text] [PDF]

Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial
Christine Stabell Benn, Birgitte Rode Diness, Adam Roth, Ernesto Nante, Ane Bærent Fisker, Ida Maria Lisse, Maria Yazdanbakhsh, Hilton Whittle, Amabelia Rodrigues, and Peter Aaby
BMJ 2008 336: 1416-1420. [Abstract] [Full Text] [PDF]

Vitamin A supplements in newborns and child survival
James M Tielsch
BMJ 2008 336: 1385-1386. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Key Opinion Leader: Are they really worth paying?
Dharmagadda Sreedhar, et al.
bmj.com, 21 Jun 2008 [Full text]
A matter of punctuation.
Henri A. Ménard
bmj.com, 21 Jun 2008 [Full text]
Something missing
Graham Kyle
bmj.com, 23 Jun 2008 [Full text]
Key Opinion Leaders and The Rule 3-30 of Evidence Based Medicine
Enrique J. Sánchez-Delgado
bmj.com, 23 Jun 2008 [Full text]
Haiku Big Pharma Loves You
Hugh Mann
bmj.com, 24 Jun 2008 [Full text]
Re: Something missing
Fiona Godlee
bmj.com, 25 Jun 2008 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ